Literature DB >> 24104882

Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative.

S Wassertheil-Smoller1, A P McGinn, N Budrys, R Chlebowski, G Y Ho, K C Johnson, D S Lane, W Li, M L Neuhouser, J Saquib, J M Shikany, Y Song, C Thomson.   

Abstract

Multivitamin use is common in the United States. It is not known whether multivitamins with minerals supplements (MVM) used by women already diagnosed with invasive breast cancer would affect their breast cancer mortality risk. To determine prospectively the effects of MVM use on breast cancer mortality in postmenopausal women diagnosed with invasive breast cancer, a prospective cohort study was conducted of 7,728 women aged 50-79 at enrollment in the women's health initiative (WHI) in 40 clinical sites across the United States diagnosed with incident invasive breast cancer during WHI and followed for a mean of 7.1 years after breast cancer diagnosis. Use of MVM supplements was assessed at WHI baseline visit and at visit closest to breast cancer diagnosis, obtained from vitamin pill bottles brought to clinic visit. Outcome was breast cancer mortality. Hazard ratios and 95 % confidence intervals (CIs) for breast cancer mortality comparing MVM users to non-users were estimated using Cox proportional hazard regression models. Analyses using propensity to take MVM were done to adjust for potential differences in characteristics of MVM users versus non-users. At baseline, 37.8 % of women reported MVM use. After mean post-diagnosis follow-up of 7.1 ± 4.1 (SD) years, there were 518 (6.7 %) deaths from breast cancer. In adjusted analyses, breast cancer mortality was 30 % lower in MVM users as compared to non-users (HR = 0.70; 95 % CI 0.55, 0.91). This association was highly robust and persisted after multiple adjustments for potential confounding variables and in propensity score matched analysis (HR = 0.76; 95 % CI 0.60-0.96). Postmenopausal women with invasive breast cancer using MVM had lower breast cancer mortality than non-users. The results suggest a possible role for daily MVM use in attenuating breast cancer mortality in women with invasive breast cancer but the findings require confirmation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24104882      PMCID: PMC3902175          DOI: 10.1007/s10549-013-2712-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

Authors:  J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

2.  Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Kathy Radimer; Bernadette Bindewald; Jeffery Hughes; Bethene Ervin; Christine Swanson; Mary Frances Picciano
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

Review 3.  Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.

Authors:  Christine M Velicer; Cornelia M Ulrich
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

5.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

6.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

7.  Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study.

Authors:  M L Lesperance; I A Olivotto; N Forde; Y Zhao; C Speers; H Foster; M Tsao; N MacPherson; A Hoffer
Journal:  Breast Cancer Res Treat       Date:  2002-11       Impact factor: 4.872

8.  Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy.

Authors:  Vummidi Giridhar Premkumar; Srinivasan Yuvaraj; Sivaprakasam Sathish; Palanivel Shanthi; Panchanatham Sachdanandam
Journal:  Vascul Pharmacol       Date:  2008-03-05       Impact factor: 5.773

9.  Development of a brief screening instrument for detecting depressive disorders.

Authors:  M A Burnam; K B Wells; B Leake; J Landsverk
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

10.  Supplement use during an intergroup clinical trial for breast cancer (S0221).

Authors:  Gary R Zirpoli; Patrick M Brennan; Chi-Chen Hong; Susan E McCann; Gregory Ciupak; Warren Davis; Joseph M Unger; G Thomas Budd; Dawn L Hershman; Halle C F Moore; James Stewart; Claudine Isaacs; Timothy Hobday; Muhammad Salim; Gabriel N Hortobagyi; Julie R Gralow; Kathy S Albain; Christine B Ambrosone
Journal:  Breast Cancer Res Treat       Date:  2013-01-10       Impact factor: 4.872

View more
  5 in total

Review 1.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

2.  Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk.

Authors:  Maria C Mora-Pinzon; Amy Trentham-Dietz; Ronald E Gangnon; Scott V Adams; John M Hampton; Elizabeth Burnside; Martin M Shafer; Polly A Newcomb
Journal:  Nutr Cancer       Date:  2018-03-14       Impact factor: 2.900

3.  Association between Post-Cancer Diagnosis Dietary Inflammatory Potential and Mortality among Invasive Breast Cancer Survivors in the Women's Health Initiative.

Authors:  Jiali Zheng; Fred K Tabung; Jiajia Zhang; Angela D Liese; Nitin Shivappa; Judith K Ockene; Bette Caan; Candyce H Kroenke; James R Hébert; Susan E Steck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-22       Impact factor: 4.254

4.  Post-cancer diagnosis dietary inflammatory potential is associated with survival among women diagnosed with colorectal cancer in the Women's Health Initiative.

Authors:  Jiali Zheng; Fred K Tabung; Jiajia Zhang; E Angela Murphy; Nitin Shivappa; Judith K Ockene; Bette Caan; Candyce H Kroenke; James R Hébert; Susan E Steck
Journal:  Eur J Nutr       Date:  2019-04-06       Impact factor: 5.614

5.  Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study.

Authors:  Heather Greenlee; Marilyn L Kwan; Isaac J Ergas; Garrett Strizich; Janise M Roh; Allegra T Wilson; Marion Lee; Karen J Sherman; Christine B Ambrosone; Dawn L Hershman; Alfred I Neugut; Lawrence H Kushi
Journal:  BMC Cancer       Date:  2014-05-29       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.